Saxenda was one of the first injectable medicines built specifically for weight loss, and for a while it was the option a lot of people heard about. Then the weekly drugs showed up, the conversation shifted, and Saxenda quietly became the one you might forget exists. It still works, it’s still prescribed, and for some people it’s still the right fit. But it asks something the newer drugs don’t: a shot every single day.
This is educational information, not medical advice. GLP-1 and GLP-1/GIP medicines — including semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), and dulaglutide (Trulicity) — are prescription-only and must be prescribed and supervised by a licensed clinician. Versions sold online as “research use only” are not FDA-approved for human use. Never start, change, or stop a dose on your own, and never source or self-inject these drugs outside of legitimate medical care. Talk to your doctor or pharmacist first, especially if you take other medications, could become pregnant, or have a health condition.
Quick answer: Saxenda is the brand name for liraglutide 3.0 mg, a once-daily injection from Novo Nordisk that’s FDA-approved for chronic weight management. It’s an older GLP-1 medicine that acts on a single receptor to curb appetite. It genuinely helps people lose weight, but on average less than the newer weekly drugs like Wegovy and Zepbound — and it needs a daily injection rather than one a week, which is why many people now start on something else.
Lose weight
Gain muscles
Eat healthy
Explore new cuisinesWhat Saxenda actually is
Saxenda is liraglutide dosed at 3.0 mg. That number matters, because the same drug shows up under a different name and a lower dose: Victoza is also liraglutide, prescribed for type 2 diabetes at doses up to 1.8 mg. Same molecule, different label, different ceiling. When liraglutide is sold for weight management, it carries the Saxenda name and climbs to that 3.0 mg target.
It belongs to a class called GLP-1 receptor agonists. GLP-1 is a hormone your gut releases after you eat, and it does a few useful things — it tells your brain you’ve had enough, it slows how fast your stomach empties, and it helps manage blood sugar. Liraglutide mimics that hormone. By acting like GLP-1 around the clock, it keeps appetite turned down so eating less doesn’t feel like a constant fight.
Here’s the structural difference from the newer headline drugs. Liraglutide hits the single GLP-1 receptor. Semaglutide does too, but it’s been engineered to last far longer in the body, which is why it only needs a weekly shot. Tirzepatide goes a step further and acts on two receptors at once — GLP-1 and GIP. That’s part of why the math on results comes out the way it does. If you want the broader picture of how this whole category works, our overview of GLP-1 medications for weight loss lays it out.
How the daily shot works in your body
Liraglutide is a subcutaneous injection — it goes into the fat just under your skin, usually the belly, thigh, or upper arm. The pen is small and the needle is short, similar to what people with diabetes have used for years. The injection itself isn’t the hard part for most people. It’s the frequency.
Once it’s in, liraglutide gets to work on appetite. Food feels less interesting. Portions that used to leave you wanting more start to feel like plenty. A lot of people describe it as the background hunger noise going quiet — you’re not white-knuckling your way past the snack drawer, you just don’t think about it as much. Because the drug also slows stomach emptying, meals sit longer and you feel full sooner.
The catch with daily dosing is that liraglutide clears your system relatively fast. That’s the whole reason it needs a shot every day instead of every week. Miss a day or two and the appetite-suppressing effect fades, and you can’t simply double up to catch up. The newer weekly drugs stay active much longer, which is why a single missed weekly dose is far more forgiving than a missed daily one.
Suggested read: Ozempic vs Wegovy: Same Drug, Different Use
Dosing: the slow climb to 3.0 mg
You don’t start at the full dose. Jumping straight to 3.0 mg would hand most people a brutal week of nausea. So Saxenda uses a step-up schedule, increasing the dose gradually to let your gut adjust.
The typical path starts at 0.6 mg daily for the first week, then steps up by 0.6 mg each week — 1.2 mg, 1.8 mg, 2.4 mg — until you reach the 3.0 mg maintenance dose, usually around week five. Your clinician sets the exact pace and can slow it down if side effects get rough. Some people park at a lower dose longer; some never need the full amount.
This slow titration is the standard playbook for GLP-1 medicines, and it’s there for a reason. Push the dose up too fast and the GI side effects spike. Climb gradually and your body has time to settle. The same logic drives the semaglutide dosage schedule, just on a weekly cadence instead of a daily one. The principle is identical: start low, go slow, let the nausea fade before the next bump.
Weight loss: honest expectations
Liraglutide 3.0 mg is a clinically tested weight-management drug, studied in randomized trials, and it does produce real, measurable weight loss along with improvements in how people feel day to day.1 This isn’t a fringe product or a guess. It earned its FDA approval through proper research.
But honesty matters here, and the honest version is this: the average weight loss with Saxenda is more modest than what the newer weekly drugs deliver. The contrast is stark when you put the numbers side by side. In the STEP 1 trial, semaglutide 2.4 mg (the dose in Wegovy) averaged around 14.9% of body weight lost over 68 weeks.2 In SURMOUNT-1, tirzepatide averaged roughly 20.9% over 72 weeks.3 Saxenda sits below both of those.
If you’re choosing between options, that gap is worth understanding before you commit to a year of daily injections.
Want a sense of where you might land? Here’s a rough projection tool.
Suggested read: Ozempic vs Mounjaro: How the Two Compare
GLP-1 Weight Loss Projection
None of these numbers are a personal guarantee — they’re trial averages, and individuals scatter widely around them. Some people on Saxenda lose a lot; some lose little. Genetics, diet, movement, sleep, and how your body responds to the drug all feed into the result. The medicine makes eating less feel doable. It doesn’t do the rest for you. For a closer head-to-head on the molecules, liraglutide vs semaglutide and semaglutide vs tirzepatide both go deeper than a single paragraph can.
Side effects and what to expect
The side effects of Saxenda are the same family you’ll hear about with every GLP-1: stomach stuff. Nausea is the big one, especially in the first few weeks and right after each dose increase. Some people also get vomiting, diarrhea, constipation, or general queasiness. For most, this eases as the body adjusts, which is exactly why the slow titration exists.1
A few things tend to help. Smaller meals, eating slower, easing up on greasy or very rich food, and not stuffing yourself once the appetite signal kicks in. If nausea is wrecking your week, that’s a conversation to have with your prescriber — they can hold you at a lower dose longer rather than pushing forward on schedule. The goal is the lowest dose that works without making you miserable.
There are more serious but less common risks, and this is genuinely where your clinician earns their keep. Liraglutide carries warnings around things like pancreatitis, gallbladder problems, and certain thyroid tumor risks seen in animal studies, and it isn’t suitable for everyone. People with a personal or family history of medullary thyroid cancer, for example, are typically steered away from it. This is exactly the kind of screening that happens during a real medical consultation and can’t be sorted out by a website.
Suggested read: Rybelsus: Oral Semaglutide Pill Explained
Daily vs weekly: the practical trade-off
This is where a lot of people make their decision, and it’s not really about the chemistry. It’s about your life.
A daily injection means remembering, every day, to do a thing. For some people that’s no big deal — they build it into a morning or evening routine and barely notice. For others, daily is a genuine grind, and the odds of missing doses go up the busier life gets. Each missed day pulls the appetite control back down, so consistency actually matters more with Saxenda than with the weekly drugs.
The weekly options changed the calculus. Once-weekly semaglutide and tirzepatide mean 52 injections a year instead of 365, and on average they deliver more weight loss on top of that. Less frequent dosing, stronger average results — it’s not a hard sell. That combination is the main reason many people now start on a weekly drug rather than Saxenda, and why some who began on liraglutide later switch.
That said, Saxenda isn’t obsolete. Insurance coverage, supply, how your body tolerates a specific drug, and your prescriber’s read on your history all play in. Some people simply do better on liraglutide. Daily dosing can even be a feature for those who like a steadier rhythm, or who tolerate the smaller daily exposure better than a larger weekly hit. There’s no universally “best” GLP-1 — there’s the one that fits your body, your budget, and your routine, and that’s a call for you and your clinician. The same is true across the class, including newer once-weekly options like Trulicity, which was built for diabetes rather than weight loss but lives in the same family.
Bottom line
Saxenda is liraglutide 3.0 mg, a once-daily GLP-1 injection that’s FDA-approved for weight management and backed by real clinical research. It works by mimicking a gut hormone that turns down appetite, it climbs from 0.6 mg to 3.0 mg through a weekly step-up to keep nausea manageable, and the side effects are mostly the usual GI ones that fade with time. Its weak point isn’t safety or effectiveness — it’s that the average weight loss runs lower than the newer weekly drugs, and it asks for a shot every day instead of once a week. That combination is why many people now start elsewhere. But the right medicine is the one that fits your body and your life, and for some people that’s still Saxenda. Have the conversation with a clinician who can look at your full history before you decide.
Kolotkin RL, et al. Improvements in health-related quality of life with liraglutide 3.0 mg compared with placebo in weight management. Clin Obes. 2016;6(4):233-242. PubMed ↩︎ ↩︎
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PubMed ↩︎
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PubMed ↩︎
